c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence

被引：0
作者：
Jaudah Al-Maghrabi
Eman Emam
Wafaey Gomaa
Moaath Saggaf
Abdelbaset Buhmeida
Mohammad Al-Qahtani
Mahmoud Al-Ahwal
机构：
[1] King Abdulaziz University,Scientific Chair for Colorectal Cancer
[2] King Abdulaziz University,Department of Pathology, Faculty of Medicine
[3] King Abdulaziz University,Center of Excellence in Genomic Medicine Research
[4] Alexandria University,Department of Pathology, Faculty of Medicine
[5] Minia University,Department of Pathology, Faculty of Medicine
[6] King Abdulaziz University,Department of Medicine, Faculty of Medicine
来源：
BMC Cancer | / 15卷
关键词：
Colorectal carcinoma; c-met proto-oncogene; Clinicopathological characteristics; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis
    Ren, Jing-Li
    Wu, Hui-Fang
    Wang, Wen-Jie
    Hu, Gui-Ming
    Gu, Bin
    Zhang, Min
    Wang, Yu-Xiang
    PANMINERVA MEDICA, 2017, 59 (01) : 97 - 106
  • [42] The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation
    Drebber, Uta
    Baldus, Stephan E.
    Nolden, Britt
    Grass, Guido
    Bollschweiler, Elfriede
    Dienes, Hans P.
    Hoelscher, Arnulf H.
    Moenig, Stefan P.
    ONCOLOGY REPORTS, 2008, 19 (06) : 1477 - 1483
  • [43] The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review
    Chen, Shouzhen
    Zhu, Yaofeng
    Cui, Jianfeng
    Wang, Yong
    Xia, Yangyang
    Song, Jing
    Cheng, Shanshan
    Zhou, Changkuo
    Zhang, Dongqing
    Zhang, Bing
    Shi, Benkang
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (08) : 532.e15 - 532.e23
  • [44] Neurofibromin Expression is Associated with Aggressive Disease and Poor Outcome in Colorectal Carcinoma
    Elzagheid, Adam
    Emaetig, Fatma
    Elsaghayer, Wesam
    Torjman, Fairouz
    Latto, Matti
    Syrjanen, Kari
    Collan, Yrjo
    Pyrhonen, Seppo
    ANTICANCER RESEARCH, 2016, 36 (10) : 5301 - 5306
  • [45] Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma
    Elzagheid, Adam
    Buhmeida, Abdelbaset
    Laato, Matti
    El-Faitori, Omran
    Syrjanen, Kari
    Collan, Yrjo
    Pyrhonen, Seppo
    APMIS, 2012, 120 (07) : 539 - 548
  • [46] Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma
    Elzagheid, Adam
    Emaetig, Fatma
    Buhmeida, Abdelbaset
    Laato, Matti
    El-Faitori, Omran
    Syrjaenen, Kari
    Collan, Yrjo
    Pyrhonen, Seppo
    TUMOR BIOLOGY, 2013, 34 (02) : 621 - 628
  • [47] Prognostic value of c-MET in oesophageal squamous cell carcinoma: a study based on the mRNA expression in TCGA database and a meta-analysis
    Zhang, Qiqi
    Li, Xiujuan
    Li, Jian
    Zhang, Zhiqiang
    FRONTIERS IN MEDICINE, 2025, 12
  • [48] Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells
    Gomes, Catarina
    Osorio, Hugo
    Pinto, Marta Teixeira
    Campos, Diana
    Oliveira, Maria Jose
    Reis, Celso A.
    PLOS ONE, 2013, 8 (06):
  • [49] miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met
    Korhan, Peyda
    Erdal, Esra
    Atabey, Nese
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 450 (04) : 1304 - 1312
  • [50] Low expression of MUC2 is associated with longer disease-free survival in patients with colorectal carcinoma
    Al-Maghrabi, Jaudah
    Sultana, Shabnum
    Gomaa, Wafaey
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2019, 25 (01) : 61 - 66
12345